Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cells|January 30, 2020
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic PathologyRolando Campanella, Laura Guarnaccia, Chiara Cordiglieri, et al.Cancers|March 25, 2022
Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology TherapeuticsLaura Guarnaccia, Stefania E Navone, Matteo M Masseroli, et al.Pituitary|February 22, 2023
Predicting tumor consistency and extent of resection in non-functioning pituitary tumorsGiorgio Fiore, Giulio Andrea Bertani, Giorgio Conte, et al.Neuro-Oncology|October 13, 2020
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomasMarco Rossi, Lorenzo Gay, Federico Ambrogi, et al.International Journal of Biological Sciences|June 16, 2025
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major playerSilvia Valtorta, Silvia Granata, Stefano de Pretis, et al.Journal of Experimental & Clinical Cancer Research : CR|January 17, 2025
V-ATPase in glioma stem cells: a novel metabolic vulnerabilityAlessandra Maria Storaci, Irene Bertolini, Cristina Martelli, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 28, 2024
A retrospective multicenter study of WHO 2021 classification-diagnosed solitary fibrous tumor of the CNS in a population from Lombardy, ItalyAndrea Salmaggi, Elisabetta Domina, Maurizio Piparo, et al.Cancer Research|October 5, 2019
MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in CancerJae Ho Seo, Young Chan Chae, Andrew V Kossenkov, et al.JAMA|December 17, 2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical TrialRoger Stupp, Sophie Taillibert, Andrew A Kanner, et al.Journal of Neurosurgical Sciences|March 23, 2023
Towards a common language in neurosurgical outcome evaluation: the NEON (NEurosurgical Outcome Network) proposalPaolo Ferroli, Silvia Schiavolin, Arianna Mariniello, et al.Pageof 6